Posts tagged defective drugs

• Families Go Before Vaccine Court

  Staff Writer | June 13, 2007 11:03 AM | 1 CommentNew York City, NY Category: FDA & Prescription Drugs
  

  Families Argue Autism Link Before Vaccine Court On June 11, 2007 court proceedings began for cases involving mercury-containing preservative thimerosal in vaccines. More than 4,800 claims have been made by families of autistic children alleging that thimerosal caused their children's autism. These families will have to go before a special "Vaccine Court" and convince a panel of three judges...

• FDA Warns of Cancer Risk with Elidel and Protopic

  Staff Writer | January 23, 2006 8:53 PM | 1 CommentNew York City, NY Category: FDA & Prescription Drugs
  

  Last week, the FDA approved two new warnings on the labeling for two skin care drugs, Elidel and Protopic. Although a causal link between these two topical drugs and certain cancers has not yet been established, patients receiving these drugs have reported a higher incidence of cancers, namely skin cancer and lymphoma. Patients taking these drugs are encouraged to consult with their doctor to...

• Certain Zicam OTC Products Recalled

  Chrissie Cole | June 17, 2009 8:33 PM | 0 CommentsNew York City, NY Category: FDA & Prescription Drugs
  

  The U.S. Food and Drug Administration (FDA) is warning consumers to avoid using certain over-the-counter Zicam products, after receiving 130 reports of loss of sense of smell associated with...

• Three Deaths Linked To Psoriasis Drug Raptiva

  Chrissie Cole | February 20, 2009 12:05 PM | 0 CommentsNew York City, NY Category: FDA & Prescription Drugs
  

  The FDA has received three reports of death from progressive multifocal leukoencephalopathy (PML) associated with the Psoriasis drug, Raptiva. A fourth case is being looked at as well. PML is a...

• Genetech Updating Rituxan Label After Patient Death

  Chrissie Cole | September 15, 2008 2:24 PM | 0 CommentsNew York City, NY Category: FDA & Prescription Drugs
  

  Genetech notified healthcare professionals of revisions to the prescribing information on the drug Rituxan after a woman who was treated with it died from a brain infection, according to the Food...

• Regranex Use May Increase Risk of Cancer

  Chrissie Cole | March 30, 2008 8:44 PM | 0 CommentsNew York City, NY Category: FDA & Prescription Drugs
  

  The U.S. Food and Drug Administration (FDA) is researching data that shows an increased risk of cancer, in diabetic patients who use Regranex Topical Gel (becaplermin) for the treatment of foot and leg ulcers.The FDA received information from a study that was performed to investigate the possibility of increased cancer risk in connection with use of Regranex.The study was based on diabetic...

• FDA Issues Alert on Tussionex

  Chrissie Cole | March 11, 2008 12:37 AM | 0 CommentsNew York City, NY Category: FDA & Prescription Drugs
  

  The FDA has issued a safety alert regarding the proper use of Tussionex Extended-Release Suspension, a potent long acting prescription cough medication, following several reports of adverse events - including death - associated with inappropriate use.The medication contains hydrocodone (a narcotic) and chlorpheniramine (an antihistamine) and is prescribed for use in adults and children six years...

• FDA Warns of Contaminated Syringes

  Chrissie Cole | January 25, 2008 12:38 AM | 0 CommentsNew York City, NY Category: FDA & Prescription Drugs
  

  The U.S. Food and Drug Administration (FDA) announced a nationwide drug recall of all lots of heparin and saline pre-filled flush syringes manufactured by AM2 PAT, Inc. under the brand name(s) Sierra Pre-filled, Inc. and B. Braun. The recall was announced after samples tested positive for Serratia marcescens, a bacterium that can cause death and serious injury. Serratia marcescens has been...

• Antidepressants Have Little Effect

  Shannon Weidemann | January 20, 2008 10:23 AM | 0 CommentsNew York City, NY Category: FDA & Prescription Drugs
  

  A study in the New England Journal of Medicine is reporting that many antidepressants do not work. The antidepressant study was performed by researchers at Oregon Health and Science University. They based their data on 74 studies that had been submitted to the FDA. The study shows that of the 74 studies registered with the Food and Drug Administration from 1987 through 2004, 38 were deemed...

• Trasylol License Suspended

  Shannon Weidemann | December 21, 2007 12:01 PM | 0 CommentsNew York City, NY Category: FDA & Prescription Drugs
  

  The anti-bleeding drug Trasylol was recalled in early November after a study revealed the risk of death was 50 percent higher than on other drugs. The BART study examined results on over 3,000 patients that had been given Trasylol and two similar drugs. The Commission on Human Medicine decided this week to suspend Trasylol's license. The CHM decision to suspend the licence was made on the...